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Trypanosoma brucei is an extracellular parasite that
causes sleeping sickness. In mammalian hosts,
trypanosomes are thought to exist in two major
niches: early in infection, they populate the blood;
later, they breach the blood-brain barrier. Working
with a well-established mouse model, we discov-
ered that adipose tissue constitutes a third major
reservoir for T. brucei. Parasites from adipose tis-
sue, here termed adipose tissue forms (ATFs), can
replicate and were capable of infecting a naive
animal. ATFs were transcriptionally distinct from
bloodstream forms, and the genes upregulated
included putative fatty acid b-oxidation enzymes.
Consistent with this, ATFs were able to utilize
exogenous myristate and form b-oxidation interme-
diates, suggesting that ATF parasites can use fatty
acids as an external carbon source. These find-
ings identify the adipose tissue as a niche for
T. brucei during its mammalian life cycle and could
potentially explain the weight loss associated with
sleeping sickness.
INTRODUCTION
Human African trypanosomiasis (HAT), also known as sleeping
sickness, is a neglected tropical disease that is almost always
fatal if left untreated. This disease is caused by Trypanosoma
brucei, a unicellular parasite that lives in the blood, lymphatic
system, and interstitial spaces of organs (reviewed in Kennedy,
2013). Disease pathology often correlates with sites of accumu-
lation of the infectious agent within its host, including the brain,
which is associated with characteristic neuropsychiatric symp-
toms and sleep disorder. Weight loss is another typical clinicalCell Host & Microbe 19, 837–848,
This is an open access article undfeature of sleeping sickness pathology (Kennedy, 2013), but is
essentially unstudied.
T. brucei is transmitted through the bite of a tsetse and
quickly adapts to the mammalian host to become what is
known as a ‘‘slender’’ bloodstream form (BSF). As parasitemia
increases, slender forms are capable of sensing population
density, and this triggers differentiation to the stumpy form,
which is pre-adapted to life in the transmitting tsetse vector
and, once there, further differentiates into procyclic form
(PCF). Several studies have shown 10%–30% of genes being
differentially expressed between BSFs and PCFs (reviewed in
Siegel et al., 2011), including genes involved in metabolism,
organelle activity, cell-cycle regulation, and endocytic activ-
ity. Recent proteomic studies also revealed around 33% of
proteins that are developmentally regulated (Butter et al.,
2013).
A major difference between BSFs and PCFs is their energy
production, with the former utilizing glucose via glycolysis
within the glycosome and the latter utilizing proline and, to a
lesser extent, other amino acids as their carbon source, via
the Krebs cycle in mitochondrion (reviewed in Szo¨o¨r et al.,
2014). To date, no fatty acid b-oxidation has been observed
as a carbon source in any life cycle stage of this parasite.
This has been a puzzling observation, as the genes required
for productive b-oxidation, including the carnitine-acyltrans-
ferases (for mitochondrial import of fatty acids), are present
in the genome.
Here, we describe an additional form of T. brucei in mamma-
lian hosts: we demonstrate that T. brucei accumulates in adipose
tissue, consistent with recent studies showing accumulation of
parasites in the lower abdomen (Claes et al., 2009; McLatchie
et al., 2013). Adipose tissue resident T. brucei have a different
metabolic profile from either slender or stumpy forms in the
blood, and this profile is consistent with their utilization of fatty
acids (myristate) as a carbon source. These experiments
describe an additional form of T. brucei life cycle and possibly
explain weight loss (wasting), one of the characteristic patholog-
ical features of sleeping sickness.June 8, 2016 ª 2016 The Author(s). Published by Elsevier Inc. 837
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
RESULTS
T. brucei Parasites Are Heterogeneously Distributed
in Mice
The well-established mouse model (C57BL/6J mice with a pleo-
morphic clone AnTat1.1E) was used to confirmweight loss during
infection as observed in humans with sleeping sickness. Parasi-
temia followed a previously described pattern: the first peak of
parasitemia occurred 5–6 days post-infection, at around 2 3
108 parasites/mL, and after approximately 4 days of undetect-
able parasitemia, parasites could be detected again with
a fluctuating parasitemia of 106–107 parasites/mL (Figure 1A). Af-
ter the first peak of parasitemia, all infected animals showed
reduced food intake and a 10%–15% decrease in body weight.
Eventually, all mice recovered normal food intake, although their
body weight remained 5% lower than that of non-infected ani-
mals (Figures 1B and S1A, available online). The weight of most
organs from mice sacrificed on days 6 and 28 post-infection
showed minimal changes relative to day 0, except fat depots,
which decreasedonaverage 43%±12%.Spleen size andweight
increased dramatically as previously reported (Figure 1C). In-
fected mice died 35 ± 2.5 days post-infection (Figure 1D).
To assess the parasite load in different organs, we used immu-
nohistochemistry at different days of infection (Figures 1E and
S1B). Parasites were consistently detected in the fat 6 days
post-infection and at later time points, while in other organs
they were seen sporadically and at very low densities. As infec-
tion progressed, we observed an increase in parasite load in
most organs, with fat, heart, brain, lung, and kidney being the
most visibly infiltrated. Parasites were always found extracellu-
larly within the interstitium of these organs. In the brain, our
data corroborate the extensively reported evidence for the local-
ization of parasites being restricted to the choroid plexuses and
meninges (Kennedy, 2013) (Figure 1E).
Histologically, thymus, lymph nodes, bone marrow, skin (of
the head and neck), salivary glands, spleen, gastrointestinal mu-
cosa, testis, and liver displayed few or no parasites (Figure 1E;
data not shown). Although parasites in the stroma of the testis
were absent, the epidymal fat body and stroma of the epididymis
(a small paired organ in the posterior end of the testis) contained
a significant number of parasites, many of which appeared as
debris, but which could explain the bioluminescence detected
by Claes et al. (2009).
Early in Infection, T. brucei Accumulate in Adipose
Tissue
Immunohistochemical staining showed parasites in the stroma
of several fat depots: gonadal, mediastinic, mesenteric, retro-
peritoneal, perirenal, and interscapular (Figure 2A). Transmission
electron microscopy (TEM) confirmed that these parasites
were indeed extravascular, as numerous trypanosomes were
observed in the interstitial space, either between adjacent adipo-
cytes or between the adipocytes and the capillaries (Figure 2B).
To quantify parasite density, we used as a proxy Trypanosome
genomic DNA (gDNA), which was quantified at 6 and 28 days
post-infection in the organs/tissues where parasites had been
detected by histology, i.e., fat, lung, heart, kidney, brain, and
blood (Figures 2C and S2A). The blood had the highest parasite
density on day 6. Among solid organs/tissues, for the same day838 Cell Host & Microbe 19, 837–848, June 8, 2016of infection, parasite density was relatively low, except for fat,
which had on average 60-fold more parasites than lung, heart,
kidney, and brain and 7-fold less than blood. On day 28 of infec-
tion, parasite density remained equally high in fat (104–105
parasites/mg), while it increased, on average, 20-fold in the
brain, heart, and lung (Figure 2C). The overall high parasite den-
sity was detected in all fat depots characterized in this study,
with no significant differences between white and brown fat de-
pots (Figure S2B; Supplemental Experimental Procedures). The
blood was the only site where we observed a decrease in para-
site density during infection, which is consistent with parasitemia
dynamics (Figures 1A and 2C). As a consequence, on day 28, fat
was the compartment with the highest parasite density (linear
mixed-effects model [LME], p < 0.0001).
Overall, the density of parasites per milligram of organ/tissue
correlated well with the density calculated as a ratio of parasite
gDNA versus mouse gDNA in each tissue (Figure S2C). We
also observed essentially the same pattern of parasite density
and the same preferential accumulation in the fat when we quan-
tified parasite RNA (qRT-PCR) instead of DNA (Figure S2D), sug-
gesting that gDNA quantification reflects accurately the number
of live parasites. Immunohistochemistry also showed accumula-
tion of parasites in fat regardless of parasite strain (EATRO1125
AnTat1.1E, Lister 427), infection route (intraperitoneal, intra-
vascular), mouse strains (C57BL/6J, BALB/c), animal gender
(male, female), or rodent species (mice, rat) (Figure S2E).
Fat represents around 14% of the body weight of a healthy
mouse (Jackson Mouse Phenome Database); thus, it is poten-
tially a very large reservoir of parasites. The number of parasites
in the organs/tissues (parasite load) was determined by multi-
plying parasite density by the weight of the organ at the corre-
sponding time of infection. For fat, we used the weight of the
six depots characterized in this work, which comprises around
25% of the total body fat. We observed that while 6 days post-
infection, the blood contained the majority of the parasites
(around 108 parasites), on day 28 the six depots of fat contained
overall more parasites than the blood, brain, and all other tested
organs combined (LME, p < 0.0001) (Figure 2D). A similar prefer-
ence for accumulation in fat was observed when the mouse
infection was initiated by a tsetse bite, which deposits metacy-
clic forms in the skin of the mouse (Figure S3) (LME, p <
0.0001). Overall, these data revealed that fat represents a major
reservoir of parasites, regardless of whether the infection was
initiated by BSFs or metacyclic forms.
Adipose Tissue Contains Replicative and Infective
Parasites
In the blood, parasites can be either replicative slender, G1-
arrested stumpy forms or intermediate forms that are not fully
differentiated (reviewed in MacGregor et al., 2012). To investi-
gate whether the parasites from fat (referred to hereafter as
adipose tissue forms [ATFs]) are replicative or not, we infected
mice with a GFP::PAD1utr reporter cell-line, in which a GFP
gene is followed by a PAD1 30 UTR that confers maximum
expression in stumpy forms (J. Sunter, A. Schwede, and
M. Carrington, personal communication; MacGregor et al.,
2012). Four and six days post-infection, blood and fat were
collected, and parasites isolated and purified. As described by
MacGregor et al. (2011), on day 4 we observed that most
Figure 1. Tissue Distribution of T. brucei during a Mouse Infection Is Heterogeneous
(A) Mean parasitemia profile of 20 mice infected with T. brucei AnTat1.1E. Parasitemia was assessed from tail blood using a hemocytometer (limit of detection is
around 4 3 105 parasites/mL). Light gray shaded area represents SEM.
(B) Variation of body weight during infection. Daily body weight measurement of control and infected mice (n = 15 per group). Light gray shaded area
represents SEM.
(C) Variation of organ weight during infection (n = 4 per group).
(D) Survival curve of T. brucei infected mice (n = 8).
(E) Representative brightfield micrographs of T. brucei distribution in several organs/tissues at days 6 and 28 post-infection, assessed by immunohistochemistry
with a non-purified rabbit anti-VSG antibody (parasites appear in brown). n = 5 per time point. Scale bar, 50 mm.
See also Figures S1 and S2.parasites in the blood were GFP negative (98%± 0.3%), while on
day 6 most parasites expressed high levels of GFP (86% ±
2.6%). Interestingly, from day 5, we noted the presence of
parasites expressing lower levels of GFP, which likely corre-
spond to differentiating intermediate forms (data not shown).As the yield of isolation of ATF parasites was very low on days
4 and 5, we analyzed these parasites only on day 6. The majority
of the ATF parasites were GFP negative (79% ± 4.6%), while
21% ± 4.6% expressed GFP, indicating that on day 6 fat con-
tains fewer stumpy/intermediate forms than blood (Figure 3A).Cell Host & Microbe 19, 837–848, June 8, 2016 839
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A B Figure 2. Fat Depots Are a Major Parasite
Reservoir
(A) Schematic representation of mice fat depots
and anti-VSG immunohistochemistry images of six
different fat depots, collected 28 days post-infec-
tion. Scale bar, 50 mm.
(B) Transmission electron micrograph of a gonadal
fat depot 6 days post-infection. Trypanosome (T)
and lymphocyte in the interstitial space, adjacent
to an adipocyte and next to a small capillary. Scale
bars, 2 and 0.5 mm in the left and right panels,
respectively.
(C) Parasite density in multiple organs/tissues
(6 and 28 days post-infection) was measured by
qRT-PCR of gDNA (quantification of T. brucei 18s
rDNA relative to the tissue/organ weight). Blood
density was assumed 1.05 g/mL. Fat value is the
average of quantification of the six depots indi-
cated in (A). Each point represents the geometric
mean of the parasite density on days 6 (n = 3–9)
and 28 post-infection (n = 3–6).
(D) Parasite load in multiple organs/tissues esti-
mated by multiplying parasite density with organ
weight at the corresponding day of infection. Each
point represents the geometric mean of the para-
site density on days 6 (n = 3–9) and 28 post-
infection (n = 3–6).
See also Figures S1–S3.To confirm if GFP-negative ATF parasites are replicative and
GFP-positive parasites are cell-cycle arrested, we stained the
parasite nuclear DNA with propidium iodide and quantified it
by flow cytometry. In all samples (blood day 4, blood day 6,
and fat day 6), we observed that GFP-negative parasites dis-
played a cell-cycle profile characteristic of replicative cells
(around 60%–70% of cells in G1, 5% in S-phase and 20%–
30% in G2/M), while GFP-positive cells were cell-cycle arrested
in G1/G0 (90%–95%) (Figure 3B). Similar data were obtained
by performing cell-cycle analysis with DyeCycle Violet (Figures
S4A and S4B), further confirming the presence of slender and
stumpy/intermediate forms in fat.
To validate the presence of stumpy/intermediate forms in fat,
we used fluorescence microscopy on an intact gonadal depot
infected with GFP::PAD1utr-expressing parasites (Figure 3C).
LipidTOX stains the lipids in the large lipid droplet of adipocytes.
Among the adipocytes, we could clearly observe many green
foci, which represent the parasite nuclei where GFP accumu-840 Cell Host & Microbe 19, 837–848, June 8, 2016lates, thus confirming the presence of
GFP-positive parasites (stumpy and/or
intermediate forms) in close proximity to
adipocytes. The presence of replicating
parasites in intact tissue was confirmed
by immunohistochemistry with an anti-
H2A antibody. Dividing nuclei were clearly
visible in close proximity to adipocytes
(Figure S4C), further confirming the fluo-
rescence-activated cell sorting (FACS)
cell-cycle data.
To test whether ATF parasites are
capable of establishing a new infection,
an infected donor mouse was sacrificed
and perfused, and several organs were collected, homogenized,
and injected intraperitoneally into recipient naive mice. Parasite-
mia was assessed daily thereafter and scored on the first day
it became detectable (Figure 3D). Mice that received blood or
a fat homogenate showed parasitemia earlier (around 3 days
post-transplantation) than animals injected with heart and brain
homogenates (around 4 days post-transplantation), consistent
with the observed parasite load in these organs (Figures 2D
and 3D). Transplant of intact gonadal fat depot also led to suc-
cessful infection of the recipient naive mice (data not shown),
suggesting that parasites can exit from an intact tissue. These re-
sults showed that parasites from fat, heart, and brain are capable
of reinvading the bloodstream and establishing a new infection.
Morphology of Adipose Tissue Forms
Although T. brucei is always extracellular, its morphology
changes during the life cycle, which may reflect a specific adap-
tation to the host niche (Wheeler et al., 2013; Bargul et al., 2016).
Figure 3. Fat Harbors Replicative Forms that Can Establish a New Infection
(A) Frequency of GFP expression measured by flow cytometry in parasites isolated from blood and fat, 4 and 6 days post-infection with aGFP::PAD1utr T. brucei
reporter cell line (n = 2–3).
(B) Cell-cycle analysis assayed by flow cytometry of propidium iodide-stained parasites (n = 2–3). The values represented are the means of the percentage of the
cell population in each cell-cycle stage and their SEM.
(C) Fluorescence microscopy of gonadal adipose tissue from a mouse infected for 6 days with GFP::PAD1utr reporter cell line. Lipid droplets were stained with
LipidTOX (red), and nuclei of GFP-expressing parasites (stumpy and/or intermediate forms) are green. Scale bar, 50 mm.
(D) Onset of parasitemia curves in mice that were injected intraperitoneally with infected organs/tissues lysates from a donor mouse. Lysates from blood, heart,
brain, and gonadal fat depot were prepared frommice sacrificed between 21 and 28 days post-infection to ensure presence of a larger number of parasites (n = 9).
See also Figure S4.
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Figure 4. Fat Is Populated by Slender, Intermediate, and Stumpy Forms
(A) Morphological features (length and width) of fixed parasites isolated from fat and blood of mice infected with GFP::PAD1utr reporter. Fat gonadal tissue was
collected on day 6 post-infection. The blood ‘‘controls’’ were obtained as follows: GFP-negative parasites were collected on day 4 post-infection (mostly slender
forms), andGFP-positive parasites were collected on day 6 post-infection (mostly stumpy forms).Morphometricmeasurements were scored from phase contrast
microscopy images, analyzed via HTIAoT, and confirmed by manual measurement. GFP negative, slender form; GFP positive, stumpy and intermediate forms.
n = 100 per group, from three independent mouse experiments. Statistical significance was assessed using a Wilcoxon rank-sum test.
(B) Representative images of parasites isolated from fat. Replicating parasites (such as the second from the left) were excluded frommorphometric analysis. DNA
was stained with DAPI (blue). GFP protein (green) is localized in the nucleus of intermediate and stumpy forms. Scale bar, 4 mm.
(C) Transmission electron micrograph and 3D tomography images of a parasite isolated from gonadal adipose tissue. Mitochondrion is represented in cyan,
glycosomes in pink, nucleus in white, and plasma membrane in yellow. Scale bar, 500 nm.
See also Figure S5 and Movie S1.ATF parasites, like BSFs, have an undulating appearance, with a
flagellum attached to the cell body and with kinetoplast DNA
positioned between nucleus and flagellar pocket (Figure 4B).842 Cell Host & Microbe 19, 837–848, June 8, 2016To characterize in more detail the morphology of ATF para-
sites, we compared the length and width of GFP::PAD1utr para-
sites isolated from adipose tissue (day 6 post-infection) and
blood (days 4 and 6 post-infection) (Figures 4A and 4B). Auto-
matic measurements of phase contrast microscopy images
were generated via HTIAoT (Wheeler et al., 2012) and confirmed
with manual measurements (Figure S5A). We observed that
slender forms (GFP negative) from blood and adipose tissue
were very similar both in length (blood, 24.39 ± 2.50 mm; fat,
24.57 ± 2.99 mm) and width (blood, 2.15 ± 0.26 mm; fat, 2.12 ±
0.26 mm). This average length is consistent with previous reports
(Tyler, 1998; Tyler et al., 2001; Bargul et al., 2016). In blood day 6
post-infection, GFP-positive parasites were, as expected,
shorter (18.43 ± 1.81 mm) andwider (3.11 ± 0.38 mm) than slender
counterparts of day 4, corresponding to the morphology of
stumpy forms (Tyler et al., 2001). Interestingly, in adipose tissue
we found not only stumpy forms, but also GFP-positive parasites
that morphologically were in between slender and stumpy forms
(length, 21.32 ± 2.73 mm; width, 2.29 ± 0.31 mm) (Tyler, 1998).
These probably correspond to the previously described blood in-
termediate forms, which, as the name suggests, are not fully
differentiated into stumpy forms, but could already express
GFP::PAD1 (MacGregor et al., 2011, 2012). These results indi-
cate that adipose tissue is populated by parasites whose
morphology has been previously found in the blood. The only
significant difference is their relative distribution: on day 6 of
infection, while blood is mostly populated by stumpy forms,
adipose tissue appears to be ‘‘delayed,’’ as we detected both
intermediate and stumpy forms.
At the ultrastructure level, ATF parasites contain all major
structures described in other stages of life cycle (Gull, 1999),
including an electron-dense coat, nucleus,mitochondrion, endo-
plasmic reticulum,Golgi apparatus, glycosomes, dense granules
and numerous vesicles compatible with endosomes, an internal
subpellicular corset of microtubules underneath plasma mem-
brane, and a flagellum attached to the cell body (Figures 4C
and S5B). Using serial 3D tomography, we observed that the sin-
gle mitochondrion of ATF parasites occupies a small volume of
parasite body and is not highly branched (Figure 4C; Movie S1).
This organization was confirmed by Mitotracker Green staining,
which showed no major differences between the mitochondrion
of parasites in blood and adipose tissue (Figure S5C; Movie S1).
Transcriptome of ATF Parasites Reveals Differences in
Several Key Regulatory Processes
During its life cycle, T. brucei adapts to its environment by
changing gene expression (reviewed in Siegel et al., 2011). To
test whether parasites within fat also adapted to the new envi-
ronment, total RNA was extracted from infected gonadal fat
depot (n = 3) on day 6, along with parasites from blood (n = 2)
on day 4 (maximizing slender and minimizing stumpy/intermedi-
ate forms), and was subjected to RNA sequencing (RNA-seq)
analysis. As expected, sequence reads from blood samples cor-
responded mainly to parasite transcripts, while sequence reads
from fat corresponded mainly to host transcripts. Nevertheless,
the 1%–9% of the sequence reads from T. brucei provided
enough statistical power to detect changes in the transcriptomes
of ATF parasites (Table S1). Two previously published RNA-seq
datasets of BSF parasites grown in culture were also included in
this analysis (Pena et al., 2014).
Unbiased clustering of gene expression profiles revealed that
ATF parasites clustered separately from parasites isolated fromblood or culture (Figure 5A), suggesting significant changes in
their overall transcriptome. Changes were identified using three
methods of differential expression analysis, and only those genes
identified by at least twomethods with an adjusted p value <0.01
were considered. These analyses showed that 2,328 genes
(around 20% of transcriptome) were differentially expressed be-
tween BSF and ATF parasites: 1,160 were upregulated in ATF
parasites and 1,178 were upregulated in BSFs (Figures 5B and
5C; Table S2).
Significant changes were found in genes involved in gene
expression regulation, cell cycle, and cell signaling (Table S3).
RNA-binding proteins play an important role in gene expression
anddifferentiation throughout theT.brucei life cycle. For example,
RNA-bindingprotein 42 (RBP42; TriTrypDB:Tb927.6.4440, http://
tritrypdb.org/tritrypdb/) binds many mRNAs involved in cellular
energy metabolism (Das et al., 2012). Upregulation of RBP42 in
ATF parasites could be involved in the metabolic rewiring when
parasites enter the fat (Table S3).
ATF parasite transcriptome also showed dramatic changes in
gene expression of various post- and co-translational modifying
enzymes that might have considerable influence on diverse
cellular processes (Table S3). A small number of genes poten-
tially acting in the cell cycle and cytokinesis was identified with
significant differential expression, including the cytoskeleton-
associated AIR9 protein and spastin, which were upregulated
(Table S3), suggesting differences in cell-cycle regulation in
these parasites. Consistent with aminor stumpy form population
in fat, we did not find enrichment of stumpy-specific genes in the
transcriptome of ATF parasites. Extracellular signaling mecha-
nisms also seem to be affected in ATF parasites, including
upregulation of TOR3, which can relate the supply of external
nutrients to internal energy levels to regulate cellular growth
(de Jesus et al., 2010).
Interestingly, although by TEM an electron-dense coat can
be observed around the parasite (Figure 2B), we found that
the transcript levels of the active variant surface glycoprotein
(VSG) (VSG AnTat1.1, CAA25971.1) are 3-fold downregulated
in adipose tissue, suggesting VSG downregulation or VSG
switching within the tissue. As the VSGnome of AnTat1.1E
clone is currently unknown, we could not test whether
silent VSGs were upregulated as a compensatory mechanism.
Genes encoding for other surface molecules, such as the
haptoglobin receptor and most procyclins, were not differen-
tially expressed.
Transcriptome of ATF Parasites Reveals Metabolic
Adaptations
One of the most evident changes in ATF transcriptome was the
upregulation of many metabolic pathways, including glycolysis,
pentose phosphate, purine salvage, sterol and lipid metabolism,
and, surprisingly, b-oxidation. Thirteen of the 14 enzymatic
steps of glycolysis were upregulated relative to BSFs (Table
S3). This may either be a response to the lower glucose concen-
tration in fat interstitial fluid relative to bloodstream, or an upre-
gulated gluconeogenesis, which relies mostly on the same
enzymes.
In ATF parasites, genes involved in three out of the five
biosynthetic steps in the pentose-phosphate pathway were
upregulated, including the rate-limiting glucose-6-phosphateCell Host & Microbe 19, 837–848, June 8, 2016 843
Figure 5. ATF Parasites Are Transcription-
ally Different from BSFs
(A) Hierarchically clustered heat map of Pearson
correlations of transcript levels (log2 transformed
RPKM) from independent RNA-seq datasets:
Lister427 parasites grown in culture (Pena et al.,
2014) (n = 2), parasites isolated from blood of
AnTat1.1-infected mice on day 4 post-infection
(n = 2), and parasites isolated from gonadal fat on
day 6 post-infection (n = 3).
(B) Heat map view of relative transcript levels for
differentially expressed genes from culture and
in vivo in parasites isolated from the two tissues
(adjusted p < 0.01 in at least two of three methods).
(C) Volcano plot displaying in red the differentially
expressed genes represented in (B). Displayed
p values and fold changes are from DESeq2.
See also Tables S1 and S2.dehydrogenase (TriTrypDB: Tb927.10.2490). This obser-
vation, taken together with the fact that numerous enzymes
(16 in total) involved in purine salvage pathway were also
upregulated, suggests that ATF parasites may increase purine
production. Interestingly, the purine phosphatases (TriTrypDB:
Tb927.8.3800 and Tb927.7.1930) and cAMP phosphodies-
terase PDEA (TriTrypDB: Tb927.10.13000) are up- and down-
regulated, respectively, suggesting that the increased pu-
rine production may be directed toward cAMP signaling
(Table S3).
ATF parasites showed significant upregulation of the alanine
and aspartate aminotransferases and the glutamate shunt,
which feed products into the tricarboxylic acid (TCA) cycle. Addi-
tionally, this cycle also appeared to bemore active, given the up-
regulation in three key steps, allowing it to process succinate,
fumarate, and 2-oxoglutarate, resembling the TCA cycle of the
T. brucei insect form (reviewed in Szo¨o¨r et al., 2014). These
changes suggest that the F0/F1 ATP synthase complex is
functional and that the associated electron transport chain is
operating in ATF parasites in a manner similar to that in PCF
parasites.
Significant changes in gene expression of lipid and sterol
metabolic pathways were also observed in ATF parasites. How-
ever, one of the most striking observations in the RNA-seq data
was the potential presence of an active fatty acid b-oxidation,844 Cell Host & Microbe 19, 837–848, June 8, 2016which produces energy from fatty acid
catabolism. This was unexpected, as
b-oxidation activity has never been de-
tected in any T. brucei life cycle stage
to date. ATF parasites showed upregula-
tion of the putative genes responsible
for the second and fourth steps of
the b-oxidation cycle (enoyl-CoA hydra-
tase and 3-ketoacyl-CoA thiolase, respec-
tively) (Figure 6A). Moreover, fatty acid
transport across the mitochondrial mem-
brane (facilitated by acyl-CoA synthases
and carnitine-acyltransferases) was up-
regulated, while fatty acid elongases
2 and 4 were downregulated, suggestingthat in ATF parasites, endocytosed fatty acids are not being elon-
gated and anabolized into more complex molecules. Instead,
they may enter the glycosomes and/or mitochondrion, where
they are catabolized via a b-oxidation pathway to form acetyl-
CoA (experimentally validated; see below and Figure 6), which
feeds into the now-active TCA cycle.
ATF Parasites Have Active Fatty Acid b-Oxidation
To investigate whether ATF parasites are capable of b-oxida-
tion, labeled myristate was used in a pulse-chase experiment
with living trypanosomes, and potential labeled b-oxidation in-
termediates were identified by gas chromatography-mass
spectrometry (GC-MS). Myristate (C14:0) was chosen, as it
is efficiently taken up and incorporated into lipids and gly-
cosylphosphatidylinositol (GPI) anchors in the slender BSF
parasites (reviewed in van Hellemond and Tielens, 2006). Iso-
lated ATF parasites were labeled with deuterated myristate
(D27-C14:0) for 1 hr and then chased with serum, following
which labeled myristate metabolites were identified. As ex-
pected, BSFs showed accumulation of D27-C14:0 during the
pulse and chase periods (Figures 6B and 6C). ATF parasites
also showed D27-C14:0 accumulation during the pulse (Fig-
ure 6B, upper panel, and Figure 6C), but the amount of D27-
C14:0 decreased significantly during the chase (Figure 6B,
lower panel, and Figure 6C). Importantly, the decrease of
Figure 6. Fatty Acid b-Oxidation Is Active in
ATF Parasites
(A) Schematic of fatty acid b-oxidation pathway.
Four enzymatic modifications are indicated by
shaded box on the fatty acid structures where
biotransformation takes place. Formulas in blue
and green indicate the myristate and b-oxidation
metabolites from the non-labeled and labeled
myristate, respectively, identified in this work.
(B) Fatty acid methyl ester (FAME) analysis by GC-
MS of D27-C14:0-labeled BSF (left) or ATF (right)
parasites for 1 hr (upper) and chased for a further
1 hr (lower). GC-MS trace shows 30–34 min (n = 3).
(C) Uptake of D27-C14:0 and b-oxidation me-
tabolites after normalization to the added internal
standard C17:0. 100% equates to the amount of
D27-C14:0 taken up by bloodstream form in the 1 hr
labeling (pulse) (n = 3). The values represented are
the means and the respective SEM.
See also Figures S6 and S7.D27-C14:0 in ATF parasites coincided with the detection
of b-oxidation metabolites derived from the labeled myris-
tate, including myristoleic acid (D25-C14:1), 3-hydroxy-myris-
tate (D25-3-OH-C14:0), and 3-oxo-myristic acid (D24-3-keto-
C14:0) (Figure 6B, right panels, and Figures 6C, S6, and S7).
The latter two metabolites were also observed to some minor
extent during the pulse (Figure 6B, upper panel, and Fig-
ure 6C), while D25-C14:1 was present in higher amount during
the chase period. Minor amounts of unlabeled 3-hydroxy-
myristrate (H26-3-OH-C14:0) were also observed in ATF para-
sites, but not BSFs (Figure 6C).
Collectively these data show that ATF parasites are able to
actively take up exogenous myristate and form b-oxidation inter-
mediates, demonstrating the existence of this pathway in try-
panosomes and suggesting that ATF parasites could in part
use fatty acid b-oxidation to satisfy their energy requirements.Cell HosDISCUSSION
A well-established feature of the unicellu-
lar, extracellular T. brucei parasite is its
ability to invade the CNS. Here, we show
that while blood is the major site of para-
site accumulation on the first peak of par-
asitemia, fat contains the highest density
and total number of parasites later in
infection (around 100- to 800-fold more
than the brain). Although the reason(s)
why parasites accumulate in adipose tis-
sue remain unknown, we clearly show it
has dramatic consequences for the para-
sites. They functionally adapt to the tissue
environment by rewiring gene expression,
including the possibility of using lipids/
fatty acids as a carbon source.
Possible Advantages to Parasite
Accumulation in the Adipose Tissue
Accumulation in the adipose tissue could
be due to several non-mutually exclusivereasons that may have provided a selective advantage during
evolution: parasites may be less efficiently eliminated by adipose
tissue-specific immune response, parasites may grow at a faster
rate, parasite differentiation may be delayed, and/or parasite en-
try in adipose tissue may be more efficient in adipose tissue than
in other organs/tissues. Depending on the dynamics of parasite
movement to/from adipose tissue, it is possible that fat acts as a
source of parasites that can repopulate the blood. This reversible
movement between blood and fat could have important impli-
cations for (1) the transmission dynamics, since stumpy forma-
tion is triggered by a quorum-sensing mechanism (MacGregor
et al., 2011), and (2) antigenic variation, if fat, for example, would
favor the appearance of new VSG variants that could later go to
the blood (Mugnier et al., 2015).
An intriguing question is whether stumpy forms could be
directly ingested by a tsetse fly from the subcutaneous fat.t & Microbe 19, 837–848, June 8, 2016 845
Although in our histological analysis we did not find a significant
number of parasites in this fat depot, it is possible we missed a
preferential skin location. Moreover, we performed this analysis
in mice infected by intraperitoneal injection, which bypasses the
skin as the first entry point of metacyclic forms. So it remains to
be determined whether subcutaneous fat is important for accu-
mulation of metacyclics and/or ATF parasites and how it impacts
transmission.
Not all Trypanosoma species occupy the same niche in the
host. T. brucei and T. evansi are mainly tissue-invading para-
sites, while T. congolense stays in smaller capillaries and venules
of tissues and T. vivax remains mainly in circulation (Losos and
Ikede, 1972). These differences have been associated with the
different swimming properties of each Trypanosoma species
(Bargul et al., 2016). Previous reports had indirectly suggested
that T. brucei parasites could be present in adipose tissue (Fer-
nandes et al., 1997; Giroud et al., 2009). Our study demonstrates
that T. brucei parasites accumulate in high numbers in the fat of
rodents. Although mouse is an accepted model to study
T. brucei infection (Giroud et al., 2009), we cannot exclude the
possibility that accumulation in adipose tissue is a result of the
selection process that happens when T. brucei infects a non-
natural host. In the future, it would be interesting to confirm
whether fat preference is a common feature of this and other
Trypanosoma species in their natural hosts and to compare
their swimming properties in different tissues/organs.
It is intriguing to note that several pathogens infect adipose
tissue. T. cruzi, the causative agent of Chagas disease in Latin
America, invades adipocytes during acute infections in mice
and humans (Ferreira et al., 2011). Also, Plasmodium berghei,
a causative agent of rodent malaria, sequesters in lungs and
fat (Franke-Fayard et al., 2005). Mycobacterium tuberculosis in-
fects adipocytes, where it accumulates in intracytoplasmic lipid
inclusions and survives in a ‘‘dormant’’ non-replicating state that
is insensitive to anti-mycobacterial drugs (Neyrolles et al., 2006).
HIV takes advantage of the fat as a viral reservoir during the
chronic stage of infection, and persistence on this reservoir is
an obstacle for treatment (Chun et al., 2015). It is possible that
persistence of T. brucei in the fat may also account for some
of the treatment failures in humans (Richardson et al., 2016).
Functional Adaptation to Host Adipose Tissue
A major observation in this work is that 20% of the genes are
differentially expressed between ATFs and BSFs, which is com-
parable with the differences between BSFs and PCFs (around
30%) and between slender and stumpy BSF forms (around
12%) (reviewed in Siegel et al., 2011). Parasites adapt to the
fat environment by changing transcript levels of genes involved
in metabolism, signaling, cell-cycle control, and RNA binding.
Using biochemical assays, we confirmed that ATF can utilize
fatty acids, i.e., myristate, and catabolize them via b-oxidation,
which could lead to the production of ATP via the TCA cycle
and oxidative phosphorylation. Therefore, it seems that para-
sites can sense and adapt to the adipose environment by rewir-
ing their gene expression, including the ability to use lipid/fatty
acid as a carbon source.
The major carbon source of BSF and PCF parasites is glucose
and proline, respectively, both of which are readily available
nutrients in the host (reviewed in Szo¨o¨r et al., 2014). Fat is, in846 Cell Host & Microbe 19, 837–848, June 8, 2016its essence, a lipid-rich environment. Therefore, it is possible
that fatty acids or some other form of lipid are released from
the host adipocytes and are endocytosed or actively transported
via a receptor-mediated process by ATF parasites (Vassella
et al., 2000). So far, only one receptor has been identified in
T. brucei as necessary for the import of LDL particles (Coppens
et al., 1987). Its transcript levels are not altered in ATF parasites,
suggesting either that this protein can be upregulated post- or
co-translationally or that lipid/fatty acid import is mediated by
yet-uncharacterized transporters.
Consumption/utilization of host’s lipids during a T. brucei
infection could contribute to the weight loss observed in patients
with sleeping sickness, cattle with Nagana, and mice infected
with T. brucei (Kennedy, 2013; Ranjithkumar et al., 2013).
Interestingly, obese mice (db/ knockout mice) infected with
T. brucei live 3-fold longer than their littermates, suggesting
that having more adipose tissue partially protected mice from
a T. brucei infection (Amole et al., 1985). Because obesity is
associated with persistent low-grade chronic inflammation in
adipose tissue (Ouchi et al., 2011), it is possible that in obese
mice, parasites get more efficiently eliminated (or controlled),
thus prolonging the survival of the host.
Most of what is known today about the mechanisms of viru-
lence, persistence, and transmission of T. brucei results from
studies performed in BSF parasites. The identification of adipose
tissue as an additional major reservoir of functionally differenti-
ated T. brucei brings a unique perspective to our understanding
of this parasite and raises several questions. What is the relative
contribution of BSF and ATF parasites for pathogenicity and host
metabolic alterations? Could fat act as a source of parasites ex-
pressing novel VSGs? What are the implications of such a large
reservoir of ATF parasites in terms of transmission?What are the
dynamics of parasite entry and exit from fat? Given that the brain
is a lipid-rich organ, which is also invaded by T. brucei, it is
obvious to ask whether these parasites also adapt their gene
expression and how this impacts brain-associated pathology.
Do ATF parasites induce changes in the host metabolism,
providing an advantage to the parasitic infection? Is the immune
response of the adipose tissue more permissive to T. brucei
parasites? Are anti-trypanosome drugs equally efficient at elim-
inating ATFs and BSFs? In sum, our findings have important con-
sequences for the understanding of parasite biology, disease,
and drug treatment efficacy.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in Supplemental Experimental
Procedures.
Animal Experiments
Animal experiments were performed according to EU regulations and
approved by the Animal Ethics Committee of Instituto de Medicina Molecular
(AEC_2011_006_LF_TBrucei_IMM). Tsetse fly infections were performed in
compliance with the regulations for biosafety and animal ethics (VPU2014_1)
and under approval from the environmental administration of the Flemish
government. Unless otherwise indicated, all infections were performed in
wild-type male C57BL/6J mice, 6–10 weeks old (Charles River, France), by
intraperitoneal injection of 2,000 T. brucei AnTat 1.1E 90-13 parasites. For
parasite counts, blood samples were taken daily from the tail vein. Organs/tis-
sues of infected mice were collected at days 6 and 28 post-infection unless
otherwise stated. Animals were sacrificed by CO2 narcosis, blood collected
by heart puncture, and mice immediately perfused. Collected organs were
snap frozen in liquid nitrogen or fixed in 10% neutral-buffered formalin. In
transplants, homogenates as well as 600 mL of blood were transplanted into
age- and sex-matched naive mice.
Histology and Electron and Fluorescence Microscopy
Formalin-fixed organs were immunostained with a non-purified rabbit serum
anti-T. brucei VSG13 antigen (which crossreacts with many VSGs) and a
non-purified rabbit serum anti-T. brucei H2A. For TEM, ultra-thin sections
(70 nm) were screened in a Hitachi H-7650 microscope. 3D reconstruction
of isolated trypanosome was done using the IMOD software package version
4.7.3 for alignment and modeling (Kremer et al., 1996).
For fluorescence analysis, the gonadal depot was stained with LipidTox,
fixed in 10% neutral-buffered formalin and embedded in Fluoromount-G.
Fluorescence images were taken using a 403 objective in a Zeiss Cell
Observer wide-fieldmicroscope. Formorphometry analysis, isolated parasites
were fixed with paraformaldehyde, DAPI stained, and embedded in vecta-
shield. Images were taken using a 633 oil objective with optional optovar
magnification (1.63) in the same wide-field microscope. Parasite measure-
ments were taken essentially as described in Wheeler et al. (2012).
The mitochondrion of isolated parasites was labeled using MitoTracker
Green (Invitrogen/Molecular Probes, M-7514) according to the manufacturer’s
instructions. Fluorescence and DIC images were acquired using a confocal
laser point-scanning microscope (Zeiss LSM 710).
Parasite Quantification
T. brucei 18S rDNAgeneswere amplified from gDNA of a knownmass of tissue
and converted into parasite number using a standard curve. For RNA quanti-
fication, the DDCt method was used by amplifying TbZFP3 and mouse Gapdh
genes from tissue total RNA.
Parasite Isolation from Tissues
Bloodstream parasites were purified over a DEAE column (Taylor et al., 1974),
while ATF parasites were isolated from gonadal fat depot by incubating the
depot in MEM or HMI11 at 37C and 150 rpm agitation for up to 40 min.
Flow Cytometry
Cell-cycle analysis was performed using propidium-iodide (PI) or Vybrant
DyeCycle violet (DCV) in fixed or live cells, respectively. PI staining was
done according to Aresta-Branco et al. (2016). For DCV staining, cell suspen-
sions were washed, and 0.5 mL DCV was added per each million isolated
parasites and incubated for 10 min at 37C. PI, DCV, and GFP intensities
were measured with BD LSRFortessa cell analyzer.
RNA-Seq
RNA and cDNA library of both blood and gonadal fat depot from days 4 and 6 of
infection, respectively,were preparedasdescribed (Penaet al., 2014), andsam-
ples sequenced in an Illumina HiSeq2000 platform. Reads were processed and
mapped to the T. brucei TREU927 genome. Differential gene expression was
analyzed, and genes were considered differentially expressed if they were
detected by at least two of the three considered algorithms (p adjusted < 0.01).
Myristate Metabolic Labeling
To evaluate myristate incorporation and metabolism, the fat isolation protocol
was performed in lipid-free minimum essential medium (MEM). Parasites were
placed in a vented tubewith 1mLMEMand starved for 30min at 37C. Starved
parasites were then labeled with 0.4 mg of radiolabeled D27-C14:0 pre-
coupled with defatted BSA for 1 hr. A total of 450 mL of the cell suspension
was washed, snap frozen in liquid nitrogen, and lyophilized in glass vials (pulse
sample). The remaining parasites were re-suspended in 500 mL MEM and
100 mL HMI11 for 1 hr at 37C, and at the end processed as for pulse sample
(chase sample). Metabolite extraction, identification, and quantification were
conducted as described in Oyola et al. (2012), with the exception that fatty
acids were released by acid hydrolysis (200 mL 6M HCl at 110C for 16 hr).
Statistical Analysis
Statistical analyses were performed by fitting LME models with mice as
random effects unless otherwise indicated. At least three independent exper-iments were considered in each case and statistical significance was set to
a = 0.05 level. Data were analyzed after logarithm transformation.
ACCESSION NUMBERS
The accession number for Lister427 culture parasites is ArrayExpress:
E-MTAB-1715. Sequence data generated as part of this study have been
submitted to the ArrayExpress database (EMBL-EBI) under accession number
ArrayExpress: E-MTAB-4061.
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